<DOC>
	<DOCNO>NCT01816646</DOCNO>
	<brief_summary>The goal clinical research study learn drug cidofovir give 1 dose directly bladder absorb body . Researchers also want measure amount study drug body different time point . The safety tolerability drug also study . Cidofovir design fight certain virus block virus cell divide .</brief_summary>
	<brief_title>Intravesical Cidofovir Hemorrhagic Cystitis</brief_title>
	<detailed_description>Study Drug Administration : If find eligible take part study , Day 1 , may receive fluid hydration vein cidofovir put bladder foley catheter . The catheter clamp shut 2 hour keep drug inside bladder . After 2 hour , catheter unclamped drug may drain . If receive bladder irrigation ( bladder flush water ) therapy hemorrhagic cystitis , therapy restart dose cidofovir . Pharmacokinetic ( PK ) Testing : On Day 1 , blood ( 2 teaspoon time ) drawn PK test approximately 1 hour ( +/- 15 minute ) dose , 1 hour ( +/- 15 minute ) , 2 hour ( +/- 15 minute ) , 4 hour ( +/- 1 hour ) , 14 hour ( +/- 1 hour ) 24 hour ( +/- 1 hour ) dose . A PK sample also draw Day 14 ( +- 2 day ) dose . PK test measure amount study drug body different time point . Virus Testing : During study , urine blood collect used research test certain virus , include type infection join study . Before cidofovir dose Day 1 , Day 3 ( +/- 1 day ) , Day 7 ( +/- 2 day ) Day 14 ( +/- 2 day ) urine blood ( 1 teaspoon ) collect virus testing . Length Study Participation : Your active study participation Day 30 follow-up phone call ( ) . If experienced side effect , study staff continue check medical record side effect become stable get well . Follow-Up : On Day 3 ( +/- 1 day ) : - You physical exam . - Your vital sign measure , ask symptom may . - Urine collect routine test - Blood ( 1 teaspoon ) drawn routine test . On Day 7 ( +/- 2 day ) : - You physical exam . - Your vital sign measure , ask symptom may . - Blood ( 1 teaspoon ) drawn routine test . - Urine collect routine test . On Day 14 ( +/- 2 day ) : - You ask symptom may . - Blood ( 1 teaspoon ) drawn routine test . - Urine collect routine test . On Day 30 ( +/- 2 day ) , contact phone ask side effect may . This call take 10 minute . This investigational study . Cidofovir give injection commercially available FDA approve treat CMV patient HIV . Its use study investigational . Up 6 patient take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Cystitis</mesh_term>
	<mesh_term>Probenecid</mesh_term>
	<mesh_term>Cidofovir</mesh_term>
	<criteria>1 . Polyoma BK adenovirus viruria establish either positive urine cytology PCR BK virus positive urine culture adenovirus . 2 . The patient either gross hematuria and/or pass blood clot . 3 . Signed informed consent form contain potential serious adverse event related cidofovir use give package insert . 4 . Hospitalized patient Foley catheter . 5 . Women childbearing potential ( Women postmenopausal great 1 year bilateral tubal ligation hysterectomy ) must agree use 2 acceptable method birth control ( e. g. , barrier method ( condom diaphragm ) another form , intrauterine device ( IUD ) hormonal birth control , study period period 2 month afterward . Males must also agree use acceptable method birth control ( barrier method ) study period 2 month afterward . 1 . Serum creatinine &gt; 2 mg/dl and/or calculate creatinine clearance &lt; 50 ml/min use CockcroftGault Creatinine Clearance formula ( CrCl ) . CrCl = { ( 140Age ) x Weight ( kg ) x 0.85 ( female ) } / { 72x Serum Creatinine ( mg/dl ) } 2 . Urine protein &gt; 100 mg/dl ( equivalent &gt; 2+ proteinuria ) 3 . Age le 18 year . 4 . Prior therapy formalin carboprost 1 mg/dL administer intravesically . 5 . Hypersensitivity cidofovir , probenecid sulfacontaining medication 6 . Patients receive prior cidofovir therapy within 2 week 7 . Prior enrollment study 8 . Women pregnant breastfeed 9 . Evidence endorgan adenoviral infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Blood And Marrow Transplantation</keyword>
	<keyword>Hemorrhagic Cystitis</keyword>
	<keyword>Bleeding bladder</keyword>
	<keyword>Foley catheter</keyword>
	<keyword>Probenecid</keyword>
	<keyword>Cidofovir</keyword>
	<keyword>Vistide</keyword>
</DOC>